Clinical outcome of extramedullary plasmacytoma

Haematologica

Volumn 85, Issue 1, 2000, Pages 47-51

  Galieni, Piero ^a,d   Cavo, Michele ^b   Pulsoni, Alessandro ^c   Avvisati, Giuseppe ^c   Bigazzi, Catia ^a   Neri, Stefano ^e   Caliceti, Umberto ^e   Benni, Monica ^b   Ronconi, Sonia ^b   Lauria, Francesco ^a  

^a Chair and Division of Hematology   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d Ospedale A Sclavo   (Italy)

^e NONE

Author keywords

Extramedullary plasmacytoma; Localized plasmacytoma; Monoclonal component; Multiple myeloma

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; MULTIPLE MYELOMA; OSTEOLYSIS; PLASMACYTOMA; PROGNOSIS; SYMPTOMATOLOGY; TUMOR LOCALIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PLASMACYTOMA; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0033951290     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Bataille R. Localized plasmacytomas. In: Salmon SE, ed. Clinics in Haematology, XI. London, Philadelphia, Toronto: WB Saunders Co; 1982. p. 113-22.
2. Wiltshaw E. The natural history of extramedullary plasmacytoma and its relation to solitary myeloma of bone and myelomatosis. Medicine 1976; 55:217-38.
3. Galieni P, Cavo M, Avvisati G, et al. Solitary plasmacytoma of bone and extramedullary plasmacytoma: two different entities? Ann Oncol 1995; 6:687-91.
4. Knowling MA, Harwood AR, Bergsagel DE, et al. Comparison of extramedullary plasmacytomas with solitary and multiple plasma cell tumors of bone. J Clin Oncol 1983; 1:255-62.
5. Holland J, Trenkner DA, Wasserman TH, Fineberg B. Plasmacytoma. Treatment results and conversion to myeloma. Cancer 1992; 69:1513-7.
6. Meis JM, Butler JJ, Osborne BM, Ordonez NG. Solitary plasmacytomas of bone and extramedullary plasmacytomas. A clinicopathologic and immunohistochemical study. Cancer 1987; 8:1475-85.
7. Kaplan EL, Meier P. Non-parametric estimation for incomplete observations. J Am Stat Ass 1958; 53:457-81.
8. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977; 1:1-39.
9. Woodruff RK, Whittle JM, Malpas JS. Solitary plasmacytoma. I: Extramedullary soft tissue plasmacytoma. Cancer 1979; 6:2340-3.
10. Kapadia SB, Desai U, Cheng VS. Extramedullary plasmacytoma of the head and neck. A clinicopathologic study of 20 cases. Medicine 1982; 61:317-29.
11. Ganjoo RK, Malpas JS. Plasmacytoma. In: Malpas JS, Bergsagel DE, Kyle RA, eds. Myeloma Biology and Management. Oxford: Medical Publications; 1995. p. 463-76.
12. 2 microglobulin in solitary plasmacytomata. Blood 1990; 76:1663.
13. Mayr NA, Wen BC, Hussey DH, et al. The role of radiation therapy in the treatment of solitary plasmacytomas. Radiother Oncol 1990; 17:293-303.
14. Mill WB, Griffith R. The role of radiation therapy in the management of plasma cell tumors. Cancer 1980; 45: 647-52.
15. Velders GA, Fibbe W, Kluin PM, Bieger R. Autologous bone marrow transplantation for intra-abdominal extramedullary plasmacytoma. Ann Hematol 1994; 69:261-4.
16. San Miguel JF, Blade Creixenti J, Garcia-Sanz R. Treatment of multiple myeloma. Haematologica 1999; 84:36-58.
17. Harousseau JL. Optimizing peripheral blood progenitor cell autologous transplantation in multiple myeloma. Haematologica 1999;84:548-53.
18. Majolino I, Vignetti M, Meloni G, et al. Autologous transplantation in multiple myeloma: a GITMO retrospective analysis on 290 patients. Haematologica 1999; 84:844-52.